SS
PRCT icon

SBI Securities’s Procept Biorobotics PRCT Stock Holding History

SBI Securities’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Sell
553
-486
-47% -$12.2K ﹤0.01% 1734
2026
Q1 		$26K Buy
1,039
+385
+59% +$10.8K ﹤0.01% 1348
2025
Q4 		$20.6K Sell
654
-51
-7% -$1.69K ﹤0.01% 1431
2025
Q3 		$25.2K Buy
705
+172
+32% +$7.85K ﹤0.01% 1359
2025
Q2 		$30.7K Buy
533
+69
+15% +$3.9K ﹤0.01% 1246
2025
Q1 		$27K Buy
464
+162
+54% +$11.1K ﹤0.01% 1217
2024
Q4 		$24.3K Buy
+302
New +$25.8K ﹤0.01% 1265

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SBI Securities's PRCT Position: Q2 2026 in Review

SBI Securities reduced its Procept Biorobotics (PRCT) stake by 47% in Q2 2026, selling an estimated $12.2K and leaving 553 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

SBI Securities first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.7K in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • SBI Securities held 553 shares of Procept Biorobotics worth $12.5K as of Q2 2026.
  • SBI Securities sold 486 Procept Biorobotics shares in Q2 2026, an estimated $12.2K.
  • Procept Biorobotics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1734 holding.
  • SBI Securities first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Procept Biorobotics position peaked at $30.7K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.